Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
33.93
+0.03 (0.09%)
At close: Jun 25, 2026, 4:00 PM EDT
34.17
+0.24 (0.71%)
After-hours: Jun 25, 2026, 7:59 PM EDT
Beam Therapeutics Employees
Beam Therapeutics had 522 employees as of March 31, 2026. The number of employees increased by 11 or 2.15% since the number was last reported on December 31, 2025.
Employees
522
Change
11
Growth
2.15%
Revenue / Employee
$314,197
Profits / Employee
-$126,398
Market Cap
3.38B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 522 | 11 | 2.15% |
| Dec 31, 2025 | 511 | 28 | 5.80% |
| Dec 31, 2024 | 483 | 47 | 10.78% |
| Dec 31, 2023 | 436 | -71 | -14.00% |
| Dec 31, 2022 | 507 | 166 | 48.68% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Alumis | 227 |
| uniQure | 221 |
| Parabilis Medicines | 145 |
BEAM News
- 7 days ago - Beam Therapeutics announces U.S. FDA clearned IND application for BEAM-304 - TheFly
- 7 days ago - Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-304 for the Treatment of Phenylketonuria (PKU) by the United States (U.S.) Food and Drug Administration - GlobeNewsWire
- 8 days ago - The Healthcare M&A Wave - Forbes
- 22 days ago - Beam Therapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Beam Therapeutics Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 5 weeks ago - Beam Therapeutics presents Phase 1/2 data for BEAM-302 - TheFly
- 5 weeks ago - Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference - GlobeNewsWire
- 6 weeks ago - Beam Therapeutics Supports AlphaDetect to Accelerate Detection of Alpha-1 - PRNewsWire